THERE are calls to prioritise vulnerable regional, rural and remote Australians for the Pfizer/BioNTech COVID-19 vaccine, which was approved for use by the Therapeutic Goods Administration (TGA) on Monday.
The National Rural Health CEO Gabrielle O’Kane said people in rural, region
Subscribe to Euroa Gazette to read the full story.